XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of reconciliation of income (loss) from continuing operations used in the basic and diluted EPS calculations

The following table presents a reconciliation of income (loss) allocable to common shareholders used in the basic and diluted EPS calculations ($ in thousands, except for per share data):

For the Years Ended December 31, 

2021

    

2020

    

2019

Net income (loss) from continuing operations

$

16,574

$

(116,308)

$

(155,575)

Net loss (income) from continuing operations attributable to noncontrolling interests

 

75

 

(337)

 

447

Preferred dividends

 

(23,496)

 

(23,496)

 

(32,495)

Net loss from continuing operations and allocable to common shareholders for basic and diluted earnings per common share

$

(6,847)

$

(140,141)

$

(187,623)

Schedule of earnings per share allocable to common shares

For the Years Ended December 31, 

2021

    

2020

    

2019

Earnings allocable to common shares:

  

 

  

 

  

Numerator for basic and diluted earnings per share:

  

 

  

 

  

Net loss from continuing operations and allocable to common shareholders

$

(6,847)

$

(140,141)

$

(187,623)

Net income from discontinued operations

121,452

85,455

489,900

Net (income) from discontinued operations attributable to noncontrolling interests

(5,620)

(11,251)

(10,730)

Net income (loss) allocable to common shareholders

$

108,985

$

(65,937)

$

291,547

Denominator for basic and diluted earnings per share:

 

  

 

  

 

  

Weighted average common shares outstanding for basic and diluted earnings per common share

 

71,831

 

75,684

 

64,696

Basic and diluted earnings per common share:(1)

 

  

 

  

 

  

Net loss from continuing operations and allocable to common shareholders

$

(0.10)

$

(1.85)

$

(2.90)

Net income from discontinued operations and allocable to common shareholders

1.61

0.98

7.41

Net income (loss) allocable to common shareholders

$

1.51

$

(0.87)

$

4.51

(1)For the year ended December 31, 2021, 2020 and 2019, the effect of certain of the Company’s restricted stock awards were anti-dilutive due to the Company having a net loss from continuing operations and allocable to common shareholders for the period. For the year ended December 31, 2021, 6,441,572 shares of the 3.125% Convertible Notes were anti-dilutive due to the Company having a net loss from continuing operations and allocable to common shareholders for the period. For the years ended December 31, 2020 and 2019, no shares of common stock would have been issuable upon conversion of the 3.125% Convertible Notes, and therefore the 3.125% Convertible Notes had no effect on diluted EPS for such periods.